Efficacy and Safety of the Two Ayurveda Drug Regimens in Uterine Fibroids: A Randomized Single-Blind Clinical Trial

Table 3

Fibroid volume change in 12^th week and 24^th week of three arms.

Fibroid volume (cm^3)	Arm I	Arm II	Arm III	value
Baseline	n = 35	n = 37	n = 30
Baseline (mean ± SD)	82.03 (173.08)	86.67 (161.20)	66.63 (151.14)	0.525
12^th week (after treatment)	n = 35	n = 37	n = 30
12^th week (mean ± SD)	68.22 (142.11)	86.29 (237.19)	112.06 (240.52)	0.322
Mean difference from baseline to 12^th week (MD)	13.81	0.38	−45.43
value	0.312	0.001	0.001
Follow-up period
24^th week (follow-up)	n = 35	n = 37	n = 00
24^th week (mean ± SD)	68.45 (137.19)	89.32 (221.58)	—	0.813^#
Mean difference from 12^th week to 24^th week (MD)	−0.22	−3.03	—
value	0.145	0.780	—

Arm I and Arm II, experimental groups; Arm III, control group; SD, standard deviation; MD, mean difference. Significant level of , based on the related samples Wilcoxon sign rank test (before and after within group). Significant level of , based on the Kruskal–Wallis value test (between group). ^#Between Arm I and Arm II.